Identification | Back Directory | [Name]
Vatalanib succinate | [CAS]
212142-18-2 | [Synonyms]
VATALANIB SUCCINATE N-(4-Chlorophenyl)-4-(4-pyridinylmethyl)-1-phthalazinamine succinate N-(4-Chlorophenyl)-4-(pyridin-4-ylmethyl)phthalazin-1-amine succinate N-(4-Chlorophenyl)-4-(4-pyridinylmethyl)-1-phthalazinamine butanedioate butanedioicacid,N-(4-chlorophenyl)-4-(pyridin-4-ylmethyl)phthalazin-1-amine | [Molecular Formula]
C24H21ClN4O4 | [MDL Number]
MFCD08435979 | [MOL File]
212142-18-2.mol | [Molecular Weight]
464.9 |
Hazard Information | Back Directory | [Uses]
Vatalanib Succinate is a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases. | [Definition]
ChEBI: A succinate salt obtained by combining vatalanib with one molar equivalent of succinic acid. It is a multi-targeted tyrosine kinase inhibitor for all isoforms of VEGFR, PDGFR and c-Kit. | [storage]
Store at -20°C |
|
Company Name: |
LGM Pharma
|
Tel: |
1-(800)-881-8210 |
Website: |
www.lgmpharma.com |
Company Name: |
BOC Sciences
|
Tel: |
|
Website: |
https://www.bocsci.com |
|